Journal of Peking University(Health Sciences) ›› 2015, Vol. 47 ›› Issue (6): 1039-1041. doi: 10.3969/j.issn.1671-167X.2015.06.029

• Article • Previous Articles     Next Articles

Tuberculous prostatic abscess following intravesical bacillus Calmette-Guérin immunotherapy: a case report

YE Hai-yun△, XU Qing-quan, HUANG Xiao-bo, MA Kai, WANG Xiao-feng   

  1. (Department of Urology, Peking University People’s Hospital, Beijing 100044, China)
  • Online:2015-12-18 Published:2015-12-18
  • Contact: YE Hai-yun E-mail:yehaiyun001@126.com

Abstract:

Intravesical bacillus Calmette-Guérin (BCG) was a common treatment for non-muscle invasive urothelial carcinoma of the bladder. The complication of prostatic abscess was rare. We reported a case of tuberculous prostatic abscess after BCG therapy. A 65-year-old man was diagnosed as bladder cancer and accepted transurethral resection of bladder tumor (TURBT) treatment. He received a 6-week induction course without any infection complication. Following the second BCG maintenance instillation, he complained of fever and dysuria. Transrectal ultrasound (TRUS) demonstrated a well-defined complex mass in the right lobe of his prostate. The diagnosis of tuberculous prostatic abscess was considered after excluding other bacterial infection. The patient was treated with an anti-tuberculous regimen of isoniazid, rifampicin, and ethambutol. The symptoms were relieved after 4 weeks of anti-tuberculous therapy. Because of the good response to the medicine, no further aspiration or drainage of prostatic abscess was carried out. The anti-tuberculous therapy had to be stopped for serious drug induced liver injury after 6 weeks of anti-tuberculous therapy. Eight weeks later of stopping anti-tuberculous therapy, the follow-up TRUS showed the disappearance of the prostatic abscess and the test of his liver function was normal. Considering the virulence of BCG is weaker than that of common tuberclebacillus, the shorter course of anti-tuberculous therapy maybe an alternative choice, and surgical drainage is not always necessary.

Key words: BCG vaccine, Urinary bladder neoplasms, Prostatic abscess, Tuberculosis, male genital, Immunotherapy

CLC Number: 

  • R737.14
[1] Jiajun LIU, Guokang LIU, Yuhu ZHU. Immune-related severe pneumonia: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 932-937.
[2] Junyong OU,Kunming NI,Lulin MA,Guoliang WANG,Ye YAN,Bin YANG,Gengwu LI,Haodong SONG,Min LU,Jianfei YE,Shudong ZHANG. Prognostic factors of patients with muscle invasive bladder cancer with intermediate-to-high risk prostate cancer [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 582-588.
[3] Shi-ming ZHAO,Tie-jun YANG,Chun-miao XU,Xiao-feng GUO,Yong-kang MA,Xue-jun CHEN,Xiang LI,Chao-hong HE. Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 701-704.
[4] Tian WANG,Xin HONG,Xiao-feng WANG. Clinical application of the needle electrode in transurethral plasmakinetic resection of bladder tumor around ureteral orifice: A report of 16 cases [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 632-636.
[5] Hai-wen HUANG,Bing YAN,Mei-xia SHANG,Li-bo LIU,Han HAO,Zhi-jun XI. Propensity-matched comparison of laparoscopic and open radical cystectomy for female patients with bladder cancer [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 698-705.
[6] WANG Huan-rui, ZHANG Wei-yu, LIU Xian-hui, HU Hao, ZHANG Xiao-peng, XU Ke-xin. Clinical application of partial cystectomy with augmentation cystoplasty for invasive bladder cancer in elderly patients [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 626-629.
[7] ZHOU Jian-hua, WANG Di, WANG Huan-rui, HOU Xiao-li,YU Wei-dong, XU Ke-xin, HU Hao. Cytotoxic effects of γδT cells on bladder cancer cells and expression of MICA/B in bladder cancer [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 595-601.
[8] LIU Jing-wei, LU Xu, YANG Zhao-min, DENG Li-juan, YANG Lin. Immune effects of specific CTLs response induced by dendritic cells pulsed with NY-ESO-1 peptide [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 840-846.
[9] HAO Han, SU Xiao-hong, ZHENG Wei, GE Peng, HE Qun, SHEN Qi, YANG Xin-yu, ZHANG Zheng, LI Xue-song, LIN Jian, ZHOU Li-qun. Radical cystectomy in patients with pathological non-muscle invasive bladder cancer [J]. Journal of Peking University(Health Sciences), 2016, 48(4): 627-631.
[10] XIAO Zong-Yu, CHEN Xiao-Juan, YANG Yi, XU Ru-Xiang. Experimental study of dendritic cells transfected with cancer stem like cells RNA against 9L brain tumors [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 661-666.
[11] LIU Yu-Qing, LU Jian, ZHAO Lei, HOU Xiao-Fei, MA Lu-Lin. Prognostic factors for intravesical recurrence after surgery for upper tract urothelial carcinoma in renal transplant recipients [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 605-610.
[12] HAO Han, WU Xin, ZHENG Wei, YU Wei, FAN Yu, HE Qun, LI Xue-Song, ZHOU Li-Qun. Characteristics of lymph node metastasis in patients undergoing radical cystectomy for bladder cancer:a retrospective single-center study of 522 cases [J]. Journal of Peking University(Health Sciences), 2014, 46(4): 524-527.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!